SunLink Health Systems, Inc., through its subsidiaries, provides healthcare products and services in the southeastern United States. It operates through two segments, Healthcare Services and Pharmacy. The Healthcare Services segment owns and operates an 84-bed community hospital, which includes an 18-bed geriatric psychiatry unit and a 66-bed nursing home in Mississippi; as well as offers information technology services. This segment also owns unimproved lands. The Pharmacy segment offers institutional and non-institutional pharmacy services; and durable medical equipment products and services, which consist of the sale and rental of products for institutional clients or to patients in institutional settings and patient-administered home care, as well as retail pharmacy products and services. SunLink Health Systems, Inc. was founded in 1959 and is based in Atlanta, Georgia.
IPO Year: 1996
Exchange: AMEX
Website: sunlinkhealth.com
4 - SUNLINK HEALTH SYSTEMS INC (0000096793) (Issuer)
425 - SUNLINK HEALTH SYSTEMS INC (0000096793) (Subject)
8-K - SUNLINK HEALTH SYSTEMS INC (0000096793) (Filer)
425 - SUNLINK HEALTH SYSTEMS INC (0000096793) (Subject)
8-K - SUNLINK HEALTH SYSTEMS INC (0000096793) (Filer)
425 - SUNLINK HEALTH SYSTEMS INC (0000096793) (Subject)
8-K/A - SUNLINK HEALTH SYSTEMS INC (0000096793) (Filer)
425 - SUNLINK HEALTH SYSTEMS INC (0000096793) (Subject)
8-K - SUNLINK HEALTH SYSTEMS INC (0000096793) (Filer)
425 - SUNLINK HEALTH SYSTEMS INC (0000096793) (Subject)
8-K - SUNLINK HEALTH SYSTEMS INC (0000096793) (Filer)
SunLink Health Systems, Inc. ("SunLink") (NYSE:SSY) today announced that SunLink convened its special meeting (the "Special Meeting") of the holders of its common stock (the "Common Stock") on July 29, 2029, and the holders of the Common Stock approved the adjournment of the Special Meeting. The Special Meeting will reconvene on Monday, August 4, 2025, at 10:00 a.m., Eastern Time, at Hyatt House Hotel, 3595 Cumberland Blvd., Atlanta, Georgia 30339. The record date for determination of the holders of the Common Stock entitled to notice of, and to vote at, the reconvened Special Meeting remains the close of business on June 20, 2025. Any proxies previously submitted by the holders of the Co
Over 99% of the SunLink shares voted to date have shown support "FOR" the merger proposal, but additional votes are needed in order to approve SunLink's proposed merger with Regional SunLink Health Systems, Inc. (NYSE:SSY) today urges its stockholders of record as of June 20, 2025 to vote in favor of all of the proposals outlined in the definitive joint proxy statement/prospectus (the "Proxy Statement") for the upcoming Special Meeting of SunLink stockholders to be held at 10:00 AM EDT on Tuesday, July 29, 2025 to approve the proposed Merger with Regional Health Properties, Inc. Robert M. Thornton, Jr., Chief Executive Officer of SunLink, commented, "We appreciate the strong support fro
SunLink Health Systems, Inc. (NYSE:SSY) today issued the following update with respect to its scheduled $0.10 per share special cash dividend approved by SunLink's Board of Directors and previously announced on July 18, 2025 (the "Special Cash Dividend"). SunLink understands that trades of SunLink common stock entered into during the period (the "due bill period") beginning July 29, 2025 (the record date for the Special Cash Dividend) and through July 30, 2025 (the payment date for the Special Cash Dividend) will have a due bill attached for the Special Cash Dividend. Due bills obligate sellers to deliver the Special Cash Dividend to the buyer. This means that persons who purchase SunLink
SunLink Health Systems, Inc. (NYSE:SSY) today announced that its Board of Directors has declared a special cash dividend (the "Special Cash Dividend") prior to the previously announced proposed merger (the "Merger") with Regional Health Properties, Inc. ("Regional") pursuant to the Amended and Restated Agreement and Plan of Merger, dated April 14, 2025, as amended (the "Merger Agreement"). The Special Cash Dividend will be $0.10 per share, payable in cash to the stockholders of record as of July 29, 2025. The aggregate estimated payment for the Special Cash Dividend is expected to be approximately $704,600, based on 7,040,603 shares of SunLink's common stock outstanding as of June 20, 2025.
It Failed to Hold Its Annual Meeting of Stockholders for the Fiscal Year Ending on June 30, 2025, as Set Forth in Section 704 of the NYSE American Company Guide SunLink Health Systems, Inc. ("SunLink") (NYSE:SSY) today announced that on Thursday, July 3, 2025, it received a deficiency letter (the "Notice") from the NYSE American LLC ("NYSE American") stating that SunLink failed to hold an annual meeting of stockholders during SunLink's fiscal year ended June 30, 2025, as required by Section 704 of the NYSE American Company Guide (the "Company Guide"). The Notice has no immediate impact on the listing of SunLink's common stock, which will continue to be listed and traded on the NYSE Amer
SunLink Health Systems, Inc. (NYSE:SSY) today announced a loss from continuing operations of $630,000 (or a loss of $0.09 per fully diluted share) for its third fiscal quarter ended March 31, 2025 compared to a loss from continuing operations of $824,000 (or a loss of $0.12 per fully diluted share) for the third fiscal quarter ended March 31, 2025. Net loss for the quarter ended March 31, 2025 was $671,000 (or a loss of $0.10 per fully diluted share) compared to a net loss of $1,396,000 (or a loss of $0.20 per fully diluted share) for the quarter ended March 31, 2024. Loss from discontinued operations was $41,000 (or a loss of $01 per fully diluted share)for the quarter ended March 31, 202
Atlanta, GA, April 15, 2025 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. ("Regional") (OTCQB:RHEP) (OTCQB:RHEPA) and SunLink Health Systems, Inc. ("SunLink") (NYSE:SSY) jointly announced today that they have entered into an amended and restated agreement and plan of merger (the "merger agreement"), pursuant to which SunLink will merge with and into Regional (the "merger") in exchange for the issuance of an aggregate of approximately 1,595,401 shares of Regional common stock and 1,408,121 shares of Regional's newly-authorized Series D 8% Cumulative Convertible Redeemable Participating Preferred Shares (the "Regional Series D Preferred Stock") with an initial liquidation preference o
SunLink Health Systems, Inc. (NYSE:SSY) today announced a loss from continuing operations of $1,070,000 (or a loss of $0.15 per fully diluted share) for its second fiscal quarter ended December 31, 2024 compared to a loss from continuing operations of $407,000 (or a loss of $0.06 per fully diluted share) for the second fiscal quarter ended December 31, 2023. During the quarter ended December 31, 2024, the Company recorded an impairment loss of $100,000 to write down the value of the net assets of its information technology business which sold in January 2025. Net loss for the quarter ended December 31, 2024 was $1,343,000 (or a loss of $0.19 per fully diluted share) compared to a net loss
Enhances Opportunity to Increase Shareholder Value Significantly Strengthens Balance Sheet Expands Regional Board with the Addition of Two Highly Qualified Industry Veterans Atlanta, GA, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. ("Regional") (NYSE:RHE) (NYSE:RHE) and SunLink Health Systems, Inc. ("SunLink") (NYSE:SSY) jointly announced today that they have entered into a definitive agreement and plan of merger (the "merger agreement"), pursuant to which SunLink will merge with and into Regional (the "merger") in exchange for the issuance of an aggregate of 1,410,000 shares of Regional common stock and 1,410,000 shares of Regional's newly-authorized Series D 8% C
SunLink Health Systems, Inc. (NYSE:SSY) today announced a loss from continuing operations of $442,000 (or a loss of $0.06 per fully diluted share) for its first fiscal quarter ended September 30, 2024 compared to a loss from continuing operations of $428,000 (or a loss of $0.06 per fully diluted share) for the first fiscal quarter ended September 30, 2023. During the quarter ended September 30, 2024, the Company sold non-core assets for cash totaling $1,465,000, which resulted in an aggregate pre-tax gain of $694,000 in the quarter ended September 30, 2024. Net loss for the quarter ended September 30, 2024 was $549,000 (or a loss of $0.08 per fully diluted share) compared to a net loss of
4 - SUNLINK HEALTH SYSTEMS INC (0000096793) (Issuer)
4 - SUNLINK HEALTH SYSTEMS INC (0000096793) (Issuer)
4 - SUNLINK HEALTH SYSTEMS INC (0000096793) (Issuer)
4 - SUNLINK HEALTH SYSTEMS INC (0000096793) (Issuer)
4 - SUNLINK HEALTH SYSTEMS INC (0000096793) (Issuer)
4 - SUNLINK HEALTH SYSTEMS INC (0000096793) (Issuer)
4 - SUNLINK HEALTH SYSTEMS INC (0000096793) (Issuer)
4 - SUNLINK HEALTH SYSTEMS INC (0000096793) (Issuer)
4 - SUNLINK HEALTH SYSTEMS INC (0000096793) (Issuer)
4 - SUNLINK HEALTH SYSTEMS INC (0000096793) (Issuer)
SC 13D/A - SUNLINK HEALTH SYSTEMS INC (0000096793) (Subject)
SC 13D/A - SUNLINK HEALTH SYSTEMS INC (0000096793) (Subject)
SC 13D/A - SUNLINK HEALTH SYSTEMS INC (0000096793) (Subject)
SC 13D/A - SUNLINK HEALTH SYSTEMS INC (0000096793) (Subject)
SC 13G/A - SUNLINK HEALTH SYSTEMS INC (0000096793) (Subject)
SC 13G/A - SUNLINK HEALTH SYSTEMS INC (0000096793) (Subject)
SunLink Health Systems, Inc. (NYSE:SSY) today issued the following update with respect to its scheduled $0.10 per share special cash dividend approved by SunLink's Board of Directors and previously announced on July 18, 2025 (the "Special Cash Dividend"). SunLink understands that trades of SunLink common stock entered into during the period (the "due bill period") beginning July 29, 2025 (the record date for the Special Cash Dividend) and through July 30, 2025 (the payment date for the Special Cash Dividend) will have a due bill attached for the Special Cash Dividend. Due bills obligate sellers to deliver the Special Cash Dividend to the buyer. This means that persons who purchase SunLink
SunLink Health Systems, Inc. (NYSE:SSY) today announced that its Board of Directors has declared a special cash dividend (the "Special Cash Dividend") prior to the previously announced proposed merger (the "Merger") with Regional Health Properties, Inc. ("Regional") pursuant to the Amended and Restated Agreement and Plan of Merger, dated April 14, 2025, as amended (the "Merger Agreement"). The Special Cash Dividend will be $0.10 per share, payable in cash to the stockholders of record as of July 29, 2025. The aggregate estimated payment for the Special Cash Dividend is expected to be approximately $704,600, based on 7,040,603 shares of SunLink's common stock outstanding as of June 20, 2025.
Atlanta, GA, April 15, 2025 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. ("Regional") (OTCQB:RHEP) (OTCQB:RHEPA) and SunLink Health Systems, Inc. ("SunLink") (NYSE:SSY) jointly announced today that they have entered into an amended and restated agreement and plan of merger (the "merger agreement"), pursuant to which SunLink will merge with and into Regional (the "merger") in exchange for the issuance of an aggregate of approximately 1,595,401 shares of Regional common stock and 1,408,121 shares of Regional's newly-authorized Series D 8% Cumulative Convertible Redeemable Participating Preferred Shares (the "Regional Series D Preferred Stock") with an initial liquidation preference o
Enhances Opportunity to Increase Shareholder Value Significantly Strengthens Balance Sheet Expands Regional Board with the Addition of Two Highly Qualified Industry Veterans Atlanta, GA, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. ("Regional") (NYSE:RHE) (NYSE:RHE) and SunLink Health Systems, Inc. ("SunLink") (NYSE:SSY) jointly announced today that they have entered into a definitive agreement and plan of merger (the "merger agreement"), pursuant to which SunLink will merge with and into Regional (the "merger") in exchange for the issuance of an aggregate of 1,410,000 shares of Regional common stock and 1,410,000 shares of Regional's newly-authorized Series D 8% C
SunLink Health Systems, Inc. (NYSE:SSY) today announced that its Board of Directors (a) declared a dividend of one one-thousandth (1/1,000th) of a share (each a "Series C Fractional Interest") of the Company's newly-designated Series C Redeemable Preferred Shares, no par value per share (the "Series C Preferred Shares"), for each outstanding common share of the Company (the "Common Shares"), payable on August 16, 2023 to shareholders of record as of 5:00 p.m. Eastern Time on August 15, 2023 and (b) its intent to call a special meeting of shareholders to consider and approve a proposal to reincorporate the Company as a Georgia corporation (the "Reincorporation Proposal"). The outstanding S